nct04208490

Eligibility

Inclusion Criterea

• NCORP PRACTICE: Willing to incorporate the web-based HN-STAR into their clinical practice
• NCORP PRACTICE: Treated >= 12 newly diagnosed cases of head and neck cancer patients within the last 12 months (or the last 12 months of available data)
• NCORP PRACTICE: Can identify at least one designated clinician who is willing to be trained on and use HN-STAR or conduct usual care for enrolled survivors
• SURVIVOR: Age >= 18 years
• SURVIVOR: Diagnosis of primary or locoregionally recurrent head and neck squamous cell carcinoma, specifically oral cavity, larynx, oropharynx, hypopharynx, and unknown squamous cell carcinoma primary
• SURVIVOR: Completed chemotherapy and/or radiation therapy (with or without surgery) with curative intent for head and neck squamous cell carcinoma =< 24 months prior to designated clinician visit
• SURVIVOR: Deemed free of disease at last assessment (per scan or clinical assessment)
• SURVIVOR: Cognitively and physically able to complete study survey per local NCORP site staff discretion
• SURVIVOR: Scheduled for a clinic visit with a provider who has agreed to participate in this study
• SURVIVOR: Willing to complete study assessments after the designated clinic visit either 1) remotely (via telephone or videoconference using smartphone, tablet, or computer) or 2) at the clinic on a clinic tablet or computer
• DESIGNATED CLINICIAN: Age >= 18 years
• DESIGNATED CLINICIAN: Doctor of Medicine (MD), Doctor of Osteopathic Medicine (DO), nurse practitioner (NP), or physician's assistant (PA)
• DESIGNATED CLINICIAN: Able to speak and read English, because the HN-STAR tool is only available in English at this time
• DESIGNATED CLINICIAN: Routinely provides care for cancer patients or survivors
• DESIGNATED CLINICIAN: Willing to complete study-specific trainings and incorporate HN-STAR or provide usual care in a routine follow-up care visit
• STAKEHOLDERS: Age >= 18 years
• STAKEHOLDERS: Member of the practice clinical or administrative team who is involved in the oversight of the delivery of head and neck cancer survivorship care or who would make decisions about implementing head and neck survivorship tools such as HN-STAR. This could include clinic administrators, nurse navigators, key clinical team members, program directors, and other staff (e.g., service line or nursing leaders)
• STAKEHOLDERS: Employed for at least one month at the practice
• STAKEHOLDERS: Able to speak and read English, because the HN-STAR tool is only available in English at this time
• PRIMARY CARE PROVIDER: Provides primary care (general preventive care) to a survivor enrolled in the HN-STAR study
• PRIMARY CARE PROVIDER: Age >= 18 years
• PRIMARY CARE PROVIDER: MD, DO, NP, or PA

Exclusion Criterea

• SURVIVOR: In active cancer treatment (including hormone therapy) for any other cancer excluding local therapy for non-melanoma skin cancer
• SURVIVOR: Head and neck tumor histology of lymphoma, adenocarcinoma or melanoma
• SURVIVOR: Recurrent, persistent, or progressive disease at last assessment (per scan or clinical assessment)
• SURVIVOR: Does not speak or read English, because the HN-STAR tool is only available in English at this time
• SURVIVOR: Received only surgery as treatment for head and neck cancer
• SURVIVOR: Current, planned enrollment, or in follow-up on another interventional symptom management study protocol, as per patient self-report or research staff members’ knowledge at the time of consent. Concurrent participation in treatment or imaging studies is allowed
• STAKEHOLDERS: Is the designated clinician at the practice
• PRIMARY CARE PROVIDER: Provides oncology care
• SURVIVOR: Evidence of a prior cancer (excluding non-melanoma skin cancer) within 3 years of the designated clinician visit